| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $5K | — | -84.7% |
| SG&A Expense | $3.5M | — | +42.2% |
| Operating Income | -$4.3M | — | -59.1% |
| Interest Expense | $74K | — | -0.5% |
| Pre-tax Income | -$6.1M | — | -129.7% |
| Income Tax | $0 | — | -100.0% |
| Net Income | -$6.1M | — | -129.7% |
| EPS (Basic) | -$0.79 | — | +56.6% |
| EPS (Diluted) | -$0.79 | — | +56.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6.2M | -67.9% | — |
| Current Assets | $23.5M | -24.1% | +725.3% |
| Total Assets | $23.9M | -23.6% | +739.4% |
| Current Liabilities | $2.0M | -39.0% | -27.9% |
| Stockholders' Equity | $21.9M | -21.7% | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.5M | — | -182.8% |
| Investing Cash Flow | -$8.5M | — | -2688.3% |
| Financing Cash Flow | -$132K | — | -117.6% |